All-in-one platform designed for BPH, Soft Tissue and Stone Management

RevoLix Therapy combines KühleDust™ technology, advanced laser engineering, StopRÖK™ kinetic control software, and a novel energy source to improve clinical outcomes compared to conventional Holmium YAG and Thulium Fiber Lasers.

Stone Management

Up to 4X Faster Dusting

Dust stones in one quarter of the time and finer stone particles than the Holmium YAG (1)

94% Reduction in Retropulsion

At comparable settings, StopRÖK provides virtually no retropulsion compared to Holmium YAG (1)

2X More Peak Power Than Thulium Fiber Lasers

Confidently fragment stones of most hardnesses and types (2)

Avoid Stone and Irrigation Overheating

KühleDust allows for optimal water and stone thermal relaxation to avoid post-procedure complications (3)

BPH and Soft Tissue

Extremely Versatile

RevoLix allows precise vaporization, resection, and incision of tissues, enabling BPH Management and other soft tissue treatments.

Clinically Proven

Only RevoLix Therapy is backed by over 600 clinical papers and 30 years of LISA Laser Thulium Innovation

Reduced Thermal Effect

RevoLix energy delivery may reduce the thermal effect that can cause unwanted tissue damage and irritative symptoms

Precise Coagulation

Thulium 0.2 mm depth of penetration and high absorption by water allows precise and rapid coagulation (4)

1, 2, 3, 4 Data on file at LISA Laser GMBH

Thulium laser for soft tissue surgery

LISA Laser Products developed the RevoLix Thulium laser and applications in soft tissue surgery on the grounds of its understanding of laser tissue interaction and the LISA competence in laser technology.

The RevoLix Thulium laser is the only laser system ever developed specifically for soft tissue surgery. The RevoLix laser wavelength is 2 micron. This wavelength is absorbed in any tissue by the ubiquitous water molecule. The RevoLix wavelength is similar to Holmium but the emission mode is continuous wave (cw) instead of pulsed – thus providing a continuous vaporization effect instead of tissue disruption as for the Holmium laser. The strong absorption of the RevoLix wavelength in tissue, in any irrigation fluid and in water provides the immediate tissue effect, limited penetration, excellent hemostasis and
protection against collateral damage.

RevoLix unifies the advantages of formerly existing surgical laser principles in a single unit. At 200 watt continuous wave the  RevoLix tissue  vaporization rate reaches 4 g/min –  a safe alternative to mechanical tissue morcellation following Thulium laser enucleation of prostate (ThuLEP, ThuVEP).

RevoLix is a multi-disciplinary surgical laser for the application in urology (surgical protocols for the treatment of BPH include vaporization (ThuVAP), vaporesection (ThuVARP), enucleation (ThuLEP) and vapoenucleation (ThuVEP) of prostate, gynaecology, neurosurgery*, ENT and pneumology.

* These products are not intended for use in clinical applications in neurosurgery in the USA.